BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26642766)

  • 1. Promising applications in drug delivery systems of a novel β-cyclodextrin derivative obtained by green synthesis.
    García A; Leonardi D; Lamas MC
    Bioorg Med Chem Lett; 2016 Jan; 26(2):602-608. PubMed ID: 26642766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of a new cyclodextrin derivative with improved properties to design oral dosage forms.
    García A; Priotti J; Codina AV; Vasconi MD; Quiroga AD; Hinrichsen LI; Leonardi D; Lamas MC
    Drug Deliv Transl Res; 2019 Feb; 9(1):273-283. PubMed ID: 30264285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterization.
    García A; Leonardi D; Salazar MO; Lamas MC
    PLoS One; 2014; 9(2):e88234. PubMed ID: 24551084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward novel antiparasitic formulations: Complexes of Albendazole desmotropes and β-cyclodextrin.
    Chattah AK; Pfund LY; Zoppi A; Longhi MR; Garnero C
    Carbohydr Polym; 2017 May; 164():379-385. PubMed ID: 28325339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinyl-β-cyclodextrin: Influence of the substitution degree on albendazole inclusion complexes probed by NMR.
    Priotti J; García A; Leonardi D; Ferreira MJ; Lamas MC; Nunes TG
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():694-702. PubMed ID: 30184797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.
    Figueiras A; Sarraguça JM; Carvalho RA; Pais AA; Veiga FJ
    Pharm Res; 2007 Feb; 24(2):377-89. PubMed ID: 17177111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and spectroscopy studies of the inclusion complex of 3-amino-5-methyl pyrazole with beta-cyclodextrin.
    Louiz S; Labiadh H; Abderrahim R
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 134():276-82. PubMed ID: 25022499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
    Wang L; Li S; Tang P; Yan J; Xu K; Li H
    Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and In Vitro Evaluation of the Complexes of Posaconazole with β- and 2,6-di-O-methyl-β-cyclodextrin.
    Tang P; Wang L; Ma X; Xu K; Xiong X; Liao X; Li H
    AAPS PharmSciTech; 2017 Jan; 18(1):104-114. PubMed ID: 26883260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (13)C and (15)N solid-state NMR studies on albendazole and cyclodextrin albendazole complexes.
    Ferreira MJ; García A; Leonardi D; Salomon CJ; Lamas MC; Nunes TG
    Carbohydr Polym; 2015 Jun; 123():130-5. PubMed ID: 25843843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexation and solubility behavior of albendazole with some cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
    Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-guest inclusion system of mangiferin with β-cyclodextrin and its derivatives.
    Yang X; Zhao Y; Chen Y; Liao X; Gao C; Xiao D; Qin Q; Yi D; Yang B
    Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):2386-91. PubMed ID: 23498273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M; Kosalec I; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.
    Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ
    J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
    Tang P; Ma X; Wu D; Li S; Xu K; Tang B; Li H
    Carbohydr Polym; 2016 May; 142():16-23. PubMed ID: 26917368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
    Jain AS; Date AA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS
    AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
    Yang B; Lin J; Chen Y; Liu Y
    Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.